These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29439343)

  • 1. Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.
    Wezyk M; Szybinska A; Wojsiat J; Szczerba M; Day K; Ronnholm H; Kele M; Berdynski M; Peplonska B; Fichna JP; Ilkowski J; Styczynska M; Barczak A; Zboch M; Filipek-Gliszczynska A; Bojakowski K; Skrzypczak M; Ginalski K; Kabza M; Makalowska I; Barcikowska-Kotowicz M; Wojda U; Falk A; Zekanowski C
    J Alzheimers Dis; 2018; 62(1):175-202. PubMed ID: 29439343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling familial Alzheimer's disease with induced pluripotent stem cells.
    Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Yoshizaki T; Yamanaka S; Okano H; Suzuki N
    Hum Mol Genet; 2011 Dec; 20(23):4530-9. PubMed ID: 21900357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
    Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
    Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
    Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated presenilin-1 endoproteolysis enhances store-operated calcium currents in neuronal cells.
    Ryazantseva M; Skobeleva K; Glushankova L; Kaznacheyeva E
    J Neurochem; 2016 Mar; 136(5):1085-95. PubMed ID: 26678016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Alzheimer's disease-linked presenilin mutants and intracellular Ca
    Greotti E; Capitanio P; Wong A; Pozzan T; Pizzo P; Pendin D
    Cell Calcium; 2019 May; 79():44-56. PubMed ID: 30822648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iPSCs-derived nerve-like cells from familial Alzheimer's disease PSEN 1 E280A reveal increased amyloid-beta levels and loss of the Y chromosome.
    Mendivil-Perez M; Velez-Pardo C; Kosik KS; Lopera F; Jimenez-Del-Rio M
    Neurosci Lett; 2019 Jun; 703():111-118. PubMed ID: 30904577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.
    Gandy S; Zhang YW; Ikin A; Schmidt SD; Bogush A; Levy E; Sheffield R; Nixon RA; Liao FF; Mathews PM; Xu H; Ehrlich ME
    J Neurochem; 2007 Aug; 102(3):619-26. PubMed ID: 17630980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presenilin-dependent expression of STIM proteins and dysregulation of capacitative Ca2+ entry in familial Alzheimer's disease.
    Bojarski L; Pomorski P; Szybinska A; Drab M; Skibinska-Kijek A; Gruszczynska-Biegala J; Kuznicki J
    Biochim Biophys Acta; 2009 Jun; 1793(6):1050-7. PubMed ID: 19111578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcriptomic landscape of neurons carrying PSEN1 mutations reveals changes in extracellular matrix components and non-coding gene expression.
    Corsi GI; Gadekar VP; Haukedal H; Doncheva NT; Anthon C; Ambardar S; Palakodeti D; Hyttel P; Freude K; Seemann SE; Gorodkin J
    Neurobiol Dis; 2023 Mar; 178():105980. PubMed ID: 36572121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties.
    Mahairaki V; Ryu J; Peters A; Chang Q; Li T; Park TS; Burridge PW; Talbot CC; Asnaghi L; Martin LJ; Zambidis ET; Koliatsos VE
    Stem Cells Dev; 2014 Dec; 23(24):2996-3010. PubMed ID: 25027006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death.
    Leschik J; Welzel A; Weissmann C; Eckert A; Brandt R
    J Neurochem; 2007 Jun; 101(5):1303-15. PubMed ID: 17298384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcilytic NPS 2143 Reduces Amyloid Secretion and Increases sAβPPα Release from PSEN1 Mutant iPSC-Derived Neurons.
    Lo Giudice M; Mihalik B; Turi Z; Dinnyés A; Kobolák J
    J Alzheimers Dis; 2019; 72(3):885-899. PubMed ID: 31640098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Alzheimer's disease presenilin-2 mutants affect Ca
    Pendin D; Fasolato C; Basso E; Filadi R; Greotti E; Galla L; Gomiero C; Leparulo A; Redolfi N; Scremin E; Vajente N; Pozzan T; Pizzo P
    Aging Clin Exp Res; 2021 Jun; 33(6):1705-1708. PubMed ID: 31606858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
    Zatti G; Burgo A; Giacomello M; Barbiero L; Ghidoni R; Sinigaglia G; Florean C; Bagnoli S; Binetti G; Sorbi S; Pizzo P; Fasolato C
    Cell Calcium; 2006 Jun; 39(6):539-50. PubMed ID: 16620965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thapsigargin affects presenilin-2 but not presenilin-1 regulation in SK-N-BE cells.
    Rivabene R; Visentin S; Piscopo P; De Nuccio C; Crestini A; Svetoni F; Rosa P; Confaloni A
    Exp Biol Med (Maywood); 2014 Feb; 239(2):213-24. PubMed ID: 24363250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Alzheimer Disease-Causing Presenilin-1 L435F Mutation Causes Increased Production of Soluble Aβ43 Species in Patient-Derived iPSC-Neurons, Closely Mimicking Matched Patient Brain Tissue.
    Oakley DH; Chung M; Klickstein N; Commins C; Hyman BT; Frosch MP
    J Neuropathol Exp Neurol; 2020 Jun; 79(6):592-604. PubMed ID: 32388561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1.
    Lazarov O; Morfini GA; Pigino G; Gadadhar A; Chen X; Robinson J; Ho H; Brady ST; Sisodia SS
    J Neurosci; 2007 Jun; 27(26):7011-20. PubMed ID: 17596450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modeling of Alzheimer's disease by the overexpression of mutant Presenilin 1 in human embryonic stem cells.
    Honda M; Minami I; Tooi N; Morone N; Nishioka H; Uemura K; Kinoshita A; Heuser JE; Nakatsuji N; Aiba K
    Biochem Biophys Res Commun; 2016 Jan; 469(3):587-92. PubMed ID: 26687948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.